Peer-reviewedCC BYJournal of human immunity
NFKB1 truncation-associated recurrent, sterile inflammation effectively treated with IL-1β blockade.
- 1Division of Immunology and Allergy, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
- 2Division of Rheumatology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
- 3Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Abstract
Recurrent, sterile inflammatory responses to surgery and trauma in a patient with a heterozygous, truncating NFKB1 variant are described. This case illustrates the autoinflammatory phenotype of truncating NFKB1 variants and highlights the prospect of a targeted, personalized immunomodulatory therapy.
Related
- The mutational and clinical spectrum of EYS-associated retinitis pigmentosa in an Eastern European and Northern Asian cohort: two recurrent founder alleles
- Metabolomics identifies endocannabinoid system remodeling during obesity associated inflammation in adipose tissue
- Optimized Super-SILAC Normalization Enables Enhanced Profiling of Histone Post-Translational Modification Changes Associated with Microbiota and Acute Inflammation
- ETSAM: effectively segmenting cell membranes in cryo-electron tomograms
- Sequence Engineering at Non-motif Modulator Residues Yields a Peptide That Effectively Targets a Single PDZ Protein in a Disease-relevant Cellular Context
BibTeX
@article{ackerman2026nfkb1,
title = {{NFKB1 truncation-associated recurrent, sterile inflammation effectively treated with IL-1β blockade.}},
author = {Kevin S Ackerman and Isabel F Armendi and Jay J Mehta and Neil Romberg},
journal = {Journal of human immunity},
year = {2026},
month = oct,
doi = {10.70962/jhi.20260157},
url = {https://europepmc.org/article/MED/42912666},
note = {CC BY},
}
RIS
TY - JOUR
TI - NFKB1 truncation-associated recurrent, sterile inflammation effectively treated with IL-1β blockade.
AU - Kevin S Ackerman
AU - Isabel F Armendi
AU - Jay J Mehta
AU - Neil Romberg
PY - 2026
DA - 2026/10/23
JO - Journal of human immunity
DO - 10.70962/jhi.20260157
UR - https://europepmc.org/article/MED/42912666
AB - Recurrent, sterile inflammatory responses to surgery and trauma in a patient with a heterozygous, truncating NFKB1 variant are described. This case illustrates the autoinflammatory phenotype of truncating NFKB1 variants and highlights the prospect of a targeted, personalized immunomodulatory therapy.
SN - 3065-8993
ER -